{"filings":[{"id":499442,"accession_number":"0001493152-26-024181","cik":835662,"company_name":"AiXin Life International, Inc.","ticker":"AIXN","form_type":"8-K","filed_at":"2026-05-18T20:15:39+00:00","items":["5.02","9.01"],"status":"ready","headline":"Director Xinliang Li resigns from AiXin Life board and audit chair role","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Mr. Xinliang Li resigned as director and from Compensation, Nominating, and Audit Committee roles effective May 18, 2026.","Resignation was not due to any disagreement with the Company on operations, policies, or practices.","No replacement director or committee appointments have been announced."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.45,"calibrated_materiality_score":0.45,"market_cap_usd":7492450.057742986,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":99138,"accession_number":"0001493152-26-016949","cik":835662,"company_name":"AiXin Life International, Inc.","ticker":"AIXN","form_type":"8-K","filed_at":"2026-04-16T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"AiXin Life appoints Qiyu Jiang as director and secretary, effective April 15, 2026","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Qiyu Jiang, 40, appointed as director and Secretary of AiXin Life and its subsidiaries.","Jiang graduated from INSEEC Paris School of Business (2015) and is a CFA Level I candidate.","Previously served as Executive Director at Jiujiang Gongqingcheng Dishi Investment Management (2017-2022).","No family relationships with any director or officer; no arrangement with any person for his appointment."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"market_cap_usd":7492450.057742986,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":114980,"accession_number":"0001493152-26-003883","cik":835662,"company_name":"AiXin Life International, Inc.","ticker":"AIXN","form_type":"8-K","filed_at":"2026-01-28T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"Director Yao-te Wang resigns from board and all officer roles at AiXin Life International","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Board accepted resignation of Yao-te Wang effective January 26, 2026.","Mr. Wang was also removed from all officer positions in the Company and its subsidiaries.","No reason for resignation or removal provided in the filing.","No replacement director or officer has been named at this time."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"market_cap_usd":7492450.057742986,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":166673,"accession_number":"0001641172-25-003553","cik":835662,"company_name":"AiXin Life International, Inc.","ticker":"AIXN","form_type":"8-K/A","filed_at":"2025-04-10T23:59:59+00:00","items":["4.02","9.01"],"status":"ready","headline":"Aixin Life restates 2021 results; net loss widens from $267K to $1.18M","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["FY2021 net loss restated to $1,176,568 from originally reported $267,236.","Restated revenue $4,241,991 vs originally $3,066,233; operating loss $1,002,273 from $26,938.","Corrections: acquisitions of Aixin Shangyan Hotel and Aixintang Pharmacies accounted as if at start of period per ASC 805-50-45.","Also corrected capital contribution from principal shareholder Quanzhong Lin; no impact on subsequent years.","Prior auditor KCCW flagged need for restatement; company filed 8-K/A with restated financials."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":7492450.057742986,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":184094,"accession_number":"0001641172-25-000411","cik":835662,"company_name":"AiXin Life International, Inc.","ticker":"AIXN","form_type":"8-K","filed_at":"2025-03-25T23:59:59+00:00","items":["4.02","9.01"],"status":"ready","headline":"Aixin Life restating 2021 financials; auditor flagged acquisition accounting","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Restating 2021 financials after former auditor KCCW identified need to correct acquisition accounting for two 2021 deals.","Acquisitions of Aixin Shangyan Hotel and Aixintang Pharmacies (both under common control) not retroactively applied from period start.","Also correcting presentation of capital contribution from a major shareholder in 2021.","Company expects to file amended 8-K with restated financials and adjustments."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":7492450.057742986,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":184093,"accession_number":"0001641172-25-000261","cik":835662,"company_name":"AiXin Life International, Inc.","ticker":"AIXN","form_type":"8-K","filed_at":"2025-03-24T23:59:59+00:00","items":["4.02","9.01"],"status":"ready","headline":"Aixin Life International to restate 2021 financials for common-control acquisitions","summary_kind":"llm","event_type":"other_material","confidence":"medium","bullets":["Company to restate 2021 financials due to accounting for acquisitions of Aixin Shangyan Hotel and Aixintang Pharmacies as entities under common control.","Prior auditor KCCW advised retroactive adjustment to present results as if acquisitions occurred at beginning of period.","Correction also includes restating comparative prior periods and reclassifying a capital contribution from a major shareholder.","Company will file an amendment with restated 2021 financial statements; no specific figures disclosed yet."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":7492450.057742986,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":184092,"accession_number":"0001493152-25-006234","cik":835662,"company_name":"AiXin Life International, Inc.","ticker":"AIXN","form_type":"8-K","filed_at":"2025-02-13T23:59:59+00:00","items":["4.01","9.01"],"status":"ready","headline":"AiXin Life International appoints YCM CPA INC. as new auditor for FY 2024","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Board approved retention of YCM CPA INC. as independent auditor for year ending Dec 31, 2024 on Feb 10, 2025.","No prior consultation with YCM CPA INC. on accounting principles, audit opinion types, or disagreements.","Engagement is for fiscal year 2024; no details on prior auditor or reason for change."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":7492450.057742986,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":184091,"accession_number":"0001493152-25-001858","cik":835662,"company_name":"AiXin Life International, Inc.","ticker":"AIXN","form_type":"8-K","filed_at":"2025-01-13T23:59:59+00:00","items":["4.01","9.01"],"status":"ready","headline":"AiXin Life International's auditor KCCW resigns effective Jan 7, 2025; no disagreements reported","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["KCCW Accountancy Corp. resigned as AiXin Life’s independent auditor, effective January 7, 2025.","KCCW served as auditor since Nov 2019; its reports for years ended Dec 31, 2023 and 2022 included a going concern qualification.","No disagreements on accounting principles or audit scope occurred during fiscal years 2023-2024 or the subsequent interim period.","Company requested and received letters from KCCW to the SEC confirming agreement with the 8-K disclosures."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":7492450.057742986,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":184090,"accession_number":"0001493152-25-001702","cik":835662,"company_name":"AiXin Life International, Inc.","ticker":"AIXN","form_type":"8-K","filed_at":"2025-01-10T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"AiXin Life International CFO Tianfeng Li resigns; Xiaowen Zheng appointed CFO","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Tianfeng Li resigned as CFO on Jan 5, 2025 effective same day; no disagreement with company's accounting or policies.","Xiaowen Zheng, 39, appointed CFO effective Jan 6, 2025; previously Financial Manager at subsidiary Chengdu Aixin Zhonghong.","Zheng's annual base salary RMB 180,000 (~$24,568) plus bonuses; fixed-term contract through June 30, 2026.","Zheng holds a B.S. in Accounting, is a Certified Tax Agent and Senior Management Accountant."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":7492450.057742986,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":308867,"accession_number":"0001493152-23-013412","cik":835662,"company_name":"AiXin Life International, Inc.","ticker":"AIXN","form_type":"8-K","filed_at":"2023-04-25T23:59:59+00:00","items":["3.01","9.01"],"status":"ready","headline":"AiXin Life receives OTCQX deficiency notice for late 10-K; faces delisting if not cured by May 18","summary_kind":"llm","event_type":"regulatory","confidence":"high","bullets":["Received OTCQX deficiency notice on April 18, 2023 for failure to file 10-K for year ended Dec 31, 2022.","Cure deadline is May 18, 2023; failure to cure results in removal from OTCQX.","Company expects to file the delinquent 10-K by the May 18 deadline.","Trading symbol AIXN on OTCQX; non-compliance with Section 3.1(l)(1)(A) of OTCQX Rules."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":7492450.057742986,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":308866,"accession_number":"0001493152-23-012575","cik":835662,"company_name":"AiXin Life International, Inc.","ticker":"AIXN","form_type":"8-K","filed_at":"2023-04-17T23:59:59+00:00","items":["2.02"],"status":"ready","headline":"AiXin Life reports FY 2022 revenue $2.7M (-11.7% YoY); operating loss $2.6M; cash plummets to $510K","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Sales revenue $2.7M, down 11.7% vs 2021; advertising revenue zero in 2022 vs $1.9M in 2021.","Operating loss widened to $2.6M from $27K loss in 2021; operating expenses rose to $5.3M.","Recorded $3.8M impairment loss from Yunnan Runcangsheng acquisition; net non-operating expense $3.8M.","Cash and equivalents fell to $510K from $8.6M; current assets $2.1M vs current liabilities $5.2M.","10-K filing expected by April 28, 2023; audit substantially complete."],"consensus_eps_estimate":null,"consensus_eps_actual":-0.021,"consensus_revenue_estimate":null,"consensus_revenue_actual":24055.0,"consensus_period":"2024-Q1","consensus_source":"xbrl_only","sentiment":"negative","materiality_score":0.85,"calibrated_materiality_score":0.85,"market_cap_usd":7492450.057742986,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":327638,"accession_number":"0001493152-23-005143","cik":835662,"company_name":"AiXin Life International, Inc.","ticker":"AIXN","form_type":"8-K/A","filed_at":"2023-02-15T23:59:59+00:00","items":["5.03","9.01"],"status":"ready","headline":"AiXin Life International announces 1-for-2 reverse stock split effective Feb 17, 2023","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["Reverse stock split ratio: 1-for-2; every two shares convert to one share.","Post-split shares outstanding approximately 24,999,945.","Ticker AIXN will have a 'D' appended for 20 business days, then revert.","New CUSIP number 009603200 assigned to post-split common stock.","Authorized shares unchanged: 500M common, 20M preferred; no fractional shares."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.45,"calibrated_materiality_score":0.45,"market_cap_usd":7492450.057742986,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":327640,"accession_number":"0001493152-23-002676","cik":835662,"company_name":"AiXin Life International, Inc.","ticker":"AIXN","form_type":"8-K","filed_at":"2023-01-27T23:59:59+00:00","items":["5.07"],"status":"ready","headline":"AiXin Life shareholders elect directors and ratify auditor at annual meeting","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["Elected Quanzhong Lin (32,840,642 votes for), Yao-Te Wang (32,839,692), Christopher Lee (32,839,692), Huiliang Jiao (32,839,706) as directors.","Ratified KCCW Accountancy Corp. as independent auditor for FY ending Dec 31, 2022; 35,411,190 votes for, none against, 25 abstentions.","Annual meeting held January 25, 2023; four directors elected for one-year terms."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.15,"market_cap_usd":7492450.057742986,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":327639,"accession_number":"0001493152-23-001284","cik":835662,"company_name":"AiXin Life International, Inc.","ticker":"AIXN","form_type":"8-K","filed_at":"2023-01-12T23:59:59+00:00","items":["5.03","9.01"],"status":"ready","headline":"AiXin Life files amendment for 1-for-2 reverse stock split, subject to FINRA approval","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Amendment filed Jan 6, 2023; each two pre-split shares combine into one new share.","Outstanding shares would reduce from 49,999,891 to approximately 24,999,946 if effected.","Completion subject to Board discretion and FINRA approval; trading symbol will remain AIXN.","Effective date and new CUSIP number to be announced publicly upon FINRA approval."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":7492450.057742986,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":327637,"accession_number":"0001493152-23-000169","cik":835662,"company_name":"AiXin Life International, Inc.","ticker":"AIXN","form_type":"8-K/A","filed_at":"2023-01-04T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"AiXin Life appoints Tianfeng Li as CFO; Jiao Huiliang to Board; Chang-Ping Lin resigns","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Tianfeng Li appointed CFO effective December 1, 2022, replacing Guolu Li.","Jiao Huiliang appointed to Board of Directors on same date.","Chang-Ping Lin resigned from Board on December 1, 2022; not due to any disagreement.","Post-appointment Board has four members."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.45,"calibrated_materiality_score":0.45,"market_cap_usd":7492450.057742986,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":345343,"accession_number":"0001493152-22-034190","cik":835662,"company_name":"AiXin Life International, Inc.","ticker":"AIXN","form_type":"8-K","filed_at":"2022-12-01T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"Aixin Life appoints Tianfeng Li as CFO and Jiao Huiliang to Board","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Tianfeng Li appointed CFO effective Dec 1, 2022; base salary $26,000 annually.","Li previously Finance Manager at subsidiary Chengdu Aixin Pharmacy since May 2019.","Li replaces Guolu Li, who had served as CFO since February 2017.","Jiao Huiliang added to board; background includes CEO roles and 40+ health-food patents.","Huiliang holds a pharmacy degree from China Pharmaceutical University and has experience in functional products."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"market_cap_usd":7492450.057742986,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":345342,"accession_number":"0001493152-22-029671","cik":835662,"company_name":"AiXin Life International, Inc.","ticker":"AIXN","form_type":"8-K/A","filed_at":"2022-10-27T23:59:59+00:00","items":["1.01","9.01"],"status":"ready","headline":"Aixin Life reduces acquisition price for Yunnan Runcansheng to RMB 31.6M (USD 4.55M)","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["Original price of RMB 45.08M reduced to RMB 31.56M (approx US$4.55M) per Supplementary Agreement 2.","Remaining RMB 26.71M (approx US$3.75M) due within 10 days after equity registration completion.","Registration delayed by COVID-19 lockdowns in Chengdu; company has already assumed operational control.","Sellers are Yunnan Sheng Shengyan Technology Co. and Chen Yun; deal for 100% of Yunnan Runcansheng."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":7492450.057742986,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":345341,"accession_number":"0001493152-22-027791","cik":835662,"company_name":"AiXin Life International, Inc.","ticker":"AIXN","form_type":"8-K/A","filed_at":"2022-10-06T23:59:59+00:00","items":["2.01","9.01"],"status":"ready","headline":"AiXin Life completes acquisition of Yunnan Runcansheng, effective Sept 30, 2022","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["Assumed operational control of Yunnan Runcansheng Technology; transfer effective Sept 30, 2022.","Remaining purchase price of RMB 39,782,600 due within 10 working days after equity registration.","Waived conditions that change and registration be completed prior to closing.","Registration delayed by COVID-19 lockdowns in Chengdu; anticipated within two weeks."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":7492450.057742986,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":345340,"accession_number":"0001493152-22-027361","cik":835662,"company_name":"AiXin Life International, Inc.","ticker":"AIXN","form_type":"8-K/A","filed_at":"2022-10-03T23:59:59+00:00","items":["9.01"],"status":"ready","headline":"Aixin Life provides audited financials for acquired Yunnan Runcansheng: 2021 revenue $783K, net loss $36K","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["Yunnan Runcansheng revenue $783,149, net loss $35,765 for year ended Dec 31, 2021.","For year ended Dec 31, 2020 (since Apr 2020 inception): revenue $7,304, net loss $22,897.","Total assets $2.87M, liabilities $2.79M, stockholders' equity $86,803 at Dec 31, 2021.","This 8-K/A amends the July 2022 8-K to include required historical and pro forma financials of the acquisition."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":7492450.057742986,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":361794,"accession_number":"0001493152-22-020283","cik":835662,"company_name":"AiXin Life International, Inc.","ticker":"AIXN","form_type":"8-K","filed_at":"2022-07-26T23:59:59+00:00","items":["1.01","9.01"],"status":"ready","headline":"Aixin Life to acquire Yunnan Runcansheng for RMB 45.1M; conditions include net worth threshold","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["Purchase price RMB 45,082,600 for 100% equity; deposit of RMB 5M paid, RMB 15M escrowed.","Acquisition contingent on audited net worth of Yunnan Runcansheng >= 90% of RMB 1.7M as of Dec 31, 2021.","Second payment of RMB 33M due within 5 days of equity registration; remaining RMB 7.08M after document transfer.","Chen Yun, a seller, will enter 5-year consulting agreement for RMB 100K/year and options for 500K shares at $6.","Sellers subject to non-compete in Yunnan/Sichuan until June 2027."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":7492450.057742986,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":418216,"accession_number":"0001493152-21-025460","cik":835662,"company_name":"AiXin Life International, Inc.","ticker":"AIXN","form_type":"8-K/A","filed_at":"2021-10-14T23:59:59+00:00","items":["9.01"],"status":"ready","headline":"Aixin Life files 8-K/A with unaudited financials for two acquisitions; Shangyan Hotel reports H1 2021 net loss of $481K","summary_kind":"llm","event_type":"other_material","confidence":"medium","bullets":["Shangyan Co revenue $748,056 for six months ended June 30, 2021; net loss $481,453.","Shangyan Co total assets $2.43M, stockholders' deficit $1.97M as of June 30, 2021.","Pharmacy Co unaudited financials for same period and pro forma combined statements also filed.","Acquisitions of Shangyan Co (RMB 7.6M/$1.16M) and Pharmacy Co were announced in May/June 2021; this amendment provides updated financials.","Shangyan Co operating loss $534,022 for H1 2021 versus $434,754 loss in H1 2020."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.4,"calibrated_materiality_score":0.4,"market_cap_usd":7492450.057742986,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":435775,"accession_number":"0001493152-21-020400","cik":835662,"company_name":"AiXin Life International, Inc.","ticker":"AIXN","form_type":"8-K/A","filed_at":"2021-08-17T23:59:59+00:00","items":["9.01"],"status":"ready","headline":"Aixin Life files financial statements for acquired pharmacies; shows 2020 net loss of $185K","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Acquired entity Chengdu Aixintang Pharmacy (9 pharmacies) had 2020 revenue of $1.26M and net loss of $185K.","Accumulated deficit at Dec 2020 was $1.19M; stockholders' deficit of $987K.","Pro forma financials also include hotel entity from a separate May 2021 acquisition.","Amendment corrects prior 8-K which misstated the acquired entity's name.","Audited and unaudited combined financials now filed for years ended 2020/2019 and Q1 2021."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":7492450.057742986,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":435774,"accession_number":"0001493152-21-019985","cik":835662,"company_name":"AiXin Life International, Inc.","ticker":"AIXN","form_type":"8-K/A","filed_at":"2021-08-16T23:59:59+00:00","items":["9.01"],"status":"ready","headline":"Acquired hotel's 2020 revenue $1.07M, net loss $689K; equity deficit $1.47M","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["2020 revenue $1.07M, down 37% YoY from $1.71M; net loss $689K vs $384K in 2019.","Stockholders' deficit of $1.47M at Dec 31, 2020, vs $0.70M deficit at end of 2019.","COVID-19 materially impacted hotel operations; many restrictions relaxed by filing date.","Unaudited Q1 2021 financials and pro forma combined statements also furnished."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":7492450.057742986,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":435776,"accession_number":"0001493152-21-016477","cik":835662,"company_name":"AiXin Life International, Inc.","ticker":"AIXN","form_type":"8-K","filed_at":"2021-07-08T23:59:59+00:00","items":["5.07"],"status":"ready","headline":"Aixin Life stockholders approve all four proposals at 2021 annual meeting","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["Elected directors: Quanzhong Lin (39.96M for), Yao-Te Wang (39.95M for), Chang-Ping Lin (39.90M for), Christopher Lee (39.92M for); 2.09M broker non-votes.","Ratified KCCW Accountancy Corp. as auditor for 2021: 39.94M for, 83,343 abstentions.","Advisory vote approved 2020 executive compensation: 39.96M for, none against; frequency set at every year (39.96M for)."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.15,"calibrated_materiality_score":0.15,"market_cap_usd":7492450.057742986,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null}],"next_cursor":null}